Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX · NASDAQ Global Select
+$0.04 today
Vol 22.41M · Avg 15.60M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-33.13%
Period High
$6.79
Period Low
$2.84
Latest
$3.23
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
ImmunityBio, Inc.
NASDAQ:IBRX
$7.41B
Liquidia Corporation
NASDAQ:LQDA
$6.02B
Cogent Biosciences, Inc.
NASDAQ:COGT
$5.80B
Denali Therapeutics Inc.
NASDAQ:DNLI
$3.70B
Beam Therapeutics Inc.
NASDAQ:BEAM
$3.36B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
89bio, Inc.
ETNB
$2.20B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$1.99B
Galapagos N.V.
GLPG
$1.84B
Sarepta Therapeutics, Inc.
NASDAQ:SRPT
$1.82B
What is the latest RXRX filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does RXRX have?
Intrinsic Alpha currently shows 20 recent filings for RXRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.